Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Thyroid cancer
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Medullary thyroid cancer''' == === '''Pathophysiology''' === ** Originates from calcitonin-producing C cells in thyroid ** Only accounts for 2% of adult thyroid cancer ** With palpable disease, 70% have nodal mets ** Usually more aggressive than differentiated cancer ** (differentiated in a sense, but not grouped with the other differentiated cancers) ** Metastasises to liver, mediastinum, lungs and bone === '''Genetic basis''' === ** ''RET'' proto-oncogene - need to test for this in all patients, as 25% of cases are associated in an autosomal dominant fashion *** MEN 2A: MTC in 100%, phaeo in 40%, PHPT in 30% *** MEN 2B: early onset aggressive MTC in 100%, phaeo in 40%, characteristic physical features (marfinoid, GIT features) *** Familial MTC: only MTC === '''Presentation''' === ** Sporadic *** Usually 30-50yo *** Palpable neck mass from primary or secondary lymph node *** Often arises in the superior lateral thyroid lobe ** Hereditary *** 10-30yo or even younger *** Often multifocal ** Can present with diarrhoea, flushing and weight loss (due to high calcitonin) ** Can get paraneoplastic syndromes from high CEA, ACTH, chromogranin, or somatostatin, which are rarely produced === '''Workup''' === ** Definitively diagnosed by FNA - stromal amyloid without thyroid follicular cells ** Genetic testing for RET ** USS - most useful modality *** Can do FNA same time *** Lateral neck looking for mets ** Serum calcitonin and CEA (baseline tumour markers, evaluate extent of disease) *** Calcitonin >500pg/mL suspicious for metastases *** Differential diagnosis for high calcitonin - autoimmune thyroiditis, HPT, lung cancer, age <3. *** CEA reflects degree of de-differentiation ** Additional imaging if TMs up, nodal disease present, serum calcitonin > 500pg/mL, or other sign of mets *** Chest CT, liver CT/MRI, bone scintigraphy and axial MRI ** Biochemical testing for phaeo and PHPT - PTH, calcium and serum metanephrines ** It seems PET is sometimes done '''Medullary thyroid carcinoma TNM staging AJCC UICC 8th edition''' {| class="wikitable" |'''Primary tumor (T)''' | | | |- |'''T category''' |'''T criteria''' | | |- |TX |Primary tumor cannot be assessed | | |- |T0 |No evidence of primary tumor | | |- |T1 |Tumor β€2 cm in greatest dimension limited to the thyroid | | |- |T1a |Tumor β€1 cm in greatest dimension limited to the thyroid | | |- |T1b |Tumor >1 cm but β€2 cm in greatest dimension limited to the thyroid | | |- |T2 |Tumor >2 cm but <4 cm in greatest dimension limited to the thyroid | | |- |T3 |Tumor β₯4 cm or with extrathyroidal extension | | |- |T3a |Tumor β₯4 cm in greatest dimension limited to the thyroid | | |- |T3b |Tumor of any size with gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles) | | |- |T4 |Advanced disease | | |- |T4a |Moderately advanced disease. Tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve. | | |- |T4b |Very advanced disease. Tumor of any size with extension toward the spine or into nearby large blood vessels, gross extrathyroidal extension invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels. | | |- |'''Regional lymph nodes (N)''' | | | |- |'''N category''' |'''N criteria''' | | |- |NX |Regional lymph nodes cannot be assessed | | |- |N0 |No evidence of locoregional lymph node metastasis | | |- |N0a |One or more cytologically or histologically confirmed benign lymph nodes | | |- |N0b |No radiologic or clinical evidence of locoregional lymph node metastasis | | |- |N1 |Metastasis to regional nodes | | |- |N1a |Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. | | |- |N1b |Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes | | |- |'''Distant metastasis (M)''' | | | |- |'''M category''' |'''M criteria''' | | |- |M0 |No distant metastasis | | |- |M1 |Distant metastasis | | |- |'''Prognostic stage groups''' | | | |- |'''When T is...''' |'''And N is...''' |'''And M is...''' |'''Then the stage group is...''' |- |T1 |N0 |M0 |I |- |T2 |N0 |M0 |II |- |T3 |N0 |M0 |II |- |T1-3 |N1a |M0 |III |- |T4a |Any N |M0 |IVA |- |T1-3 |N1b |M0 |IVA |- |T4b |Any N |M0 |IVB |- |Any T |Any N |M1 |IVC |} === '''Treatment''' === ** Neoadjuvant therapy *** Consider for those with significant burden of metastatic disease ** Clinically evident disease *** Must differentiate between sporadic and inherited from the start! **** If phaeo is also present, do adrenalectomy first **** If MEN2A is present check for PHPT and do a four-gland exploration simultaneously (enlarged parathyroids should be resected, even if eucalcaemic) **** If RET is positive, guidelines dictate when prophylactic thyroidectomy should take place based on genotype **** If MEN2B is present, prophylactic total thyroidectomy and bilateral central neck dissection should be performed <1yo *** '''Needs total thyroidectomy + bilateral central neck dissection''' even if N0. Lateral neck dissection performed for biopsy-proven lateral neck disease or high suspicion of lateral neck disease based on high serum calcitonin (number not really fixed, some say 250, some say 500, make an overall risk stratification). ** Offer prophylactic total thyroidectomy to those with RET *** Aim to do it before central neck dissection is required *** Timing depends largely on specific ''RET'' mutation ** Adjuvant therapy *** Traditional systemic chemotherapy is ineffective *** Tyrosine kinase receptor therapies can be useful - vandetanib *** EBRT to neck and mediastinum for those with incompletely resected or high risk tumours (although no benefit to overall survival) === '''Follow-up''' === ** Start regular calcitonin/CEA 3 months post-op *** Negative/normal: 2x six-monthly tests, then annually *** Elevated: imaging workup for persistent or recurrent disease === '''Prognosis''' === ** 50% overall disease recurrence ** 80% 10-year survival overall ** N0: 5 year survival 95% ** N1: 5 year survival 75% ** M1: 5 year survival 35%
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Thyroid cancer
(section)
Add topic